Cargando…
Effectiveness and safety of fibrinolytic therapy in critically ill patients with COVID-19 with ARDS: protocol for a prospective meta-analysis
INTRODUCTION: The use of fibrinolytic therapy has been proposed in severe acute respiratory distress syndrome (ARDS). During the COVID-19 pandemic, anticoagulation has received special attention due to the frequent findings of microthrombi and fibrin deposits in the lungs and other organs. Therefore...
Autores principales: | Kovács, Emőke Henrietta, Dembrovszky, Fanni, Ocskay, Klementina, Szabó, László, Hegyi, Péter, Molnar, Zsolt, Tánczos, Krisztián |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9515457/ https://www.ncbi.nlm.nih.gov/pubmed/36167378 http://dx.doi.org/10.1136/bmjopen-2022-063855 |
Ejemplares similares
-
Investigating the association between IL-6 antagonist therapy and blood coagulation in critically ill patients with COVID-19: a protocol for a prospective, observational, multicentre study
por: Kovács, Emőke Henrietta, et al.
Publicado: (2022) -
Higher Dose Anticoagulation Cannot Prevent Disease Progression in COVID-19 Patients: A Systematic Review and Meta-Analysis
por: Kovács, Emőke Henrietta, et al.
Publicado: (2022) -
Fibrinolytic therapy in patients with COVID-19 and ARDS: protocol for a systematic review and meta-analysis
por: Savioli, Felicio, et al.
Publicado: (2023) -
Persistence of patient and family experiences of critical illness
por: Hirshberg, Eliotte L, et al.
Publicado: (2020) -
Severe ARDS in a critically ill influenza patient with invasive pulmonary aspergillosis
por: Pietsch, Urs, et al.
Publicado: (2016)